For the year ending March 2016, Tate & Lyle expects adjusted profit before tax in line with 2015, assuming it completes the exit of its European bulk ingredients business. Photograph: Getty Images/iStockphoto

Britain’s Tate & Lyle reported lower full-year profit in line with its forecast and signalled this year would be just as tough as it overhauls its(...)

Vodafone has bought individual cable operators in certain European markets but a purchase of Liberty would broaden its fixed-line business in one go

Vodafone’s shares jumped 4 per cent after the chairman of Liberty Global, John Malone, said the two companies would make a “great fit”, reigniting lon(...)

The move into smartphone apps could further dent console sales, some analysts said

Shares in Japanese video game maker Nintendo on Wednesday notched their biggest daily gain since listing as investors cheered the decision by the cre(...)

Euro bank notes and Swiss franc notes. The shockwaves from Switzerland’s decision to scrap its currency ceiling against the euro continue to reverberate

Foreign exchange brokers across the world reported escalating losses yesterday as the shockwaves from Switzerland’s decision to scrap its currency cei(...)

UK chancellor of the exchequer George Osborne. He is to sell some of government’s stake in Lloyds.

UK chancellor of the exchequer George Osborne said his government will cut its stake in Lloyds banking group in the run-up to May’s general election, (...)

J&J seeks in excess of $5 billion in damages and interest from Boston Scientific, a potentially massive judgment against a company that as of Tuesday had a market capitalisation of $17.8 billion

Nearly a decade after losing a bidding war for device maker Guidant to Boston Scientific Corp, Johnson & Johnson finally has a chance for payback (...)

Sales forecasts for Novartis’s new heart failure drug are being ramped up by analysts after good clinical trial results for a medicine doctors expect to transform treatment of the deadly disease.

Sales forecasts for Novartis’s new heart failure drug are being ramped up by analysts after strikingly good clinical trial results for a medicine doct(...)

Credit Agricole saw its profit almost wiped out in the second quarter as a result of its holding in  troubled Portuguese lender Banco Espirito Santo. Photograph: Hugo Correia/Reuters

Credit Agricole, France’s third- largest bank by market value, said profit was almost wiped out in the second quarter on charges tied to its stake in (...)

A sign of US bank Goldman Sachs on the floor of the New York Stock Exchange. EPA/JUSTIN LANE

Wall Street firms led by Goldman Sachs Group are close to buying a stake in chat and instant messaging startup Perzo in pursuit of an alternative to a(...)

Blister packs of over-the-counter allergy medicines, manufactured by Perrigo. Perrigo agreed to buy Irish drug company Elan for $8.6 billion in 2013, thereby gaining a low-tax base for international expansion. Now it is being cited as a potential acquisition target for larger companies looking to pursue a similar strategy. Photograph: Andrew Harrer/Bloomberg

Dublin based drugmaker Perrigo may join Swiss based Actelion and UK-based medical device company Smith and Nephew as acquisition targets for US healt(...)